POLISCOPE
Back to feed
HR4231FEDERALin_committee
High Impact

Treat and Reduce Obesity Act of 2025 expands Medicare coverage for obesity treatments

Original title: Treat and Reduce Obesity Act of 2025

June 27, 2025

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Jun 27, 2025
Lead sponsor

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This legislation would change the scope of services covered by Medicare, potentially lowering out-of-pocket costs for millions of seniors and individuals with disabilities seeking medical weight management.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare beneficiaries

Individuals enrolled in Medicare may gain access to previously uncovered weight management medications and counseling services.

Healthcare providers

Physicians and clinicians may see changes in billing and coverage protocols for obesity-related treatments.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

The Treat and Reduce Obesity Act of 2025 expands coverage to include medications for weight management and chronic weight-related conditions. This bill aims to increase access to obesity-related counseling and pharmaceutical treatments for Medicare beneficiaries.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This legislation would change the scope of services covered by Medicare, potentially lowering out-of-pocket costs for millions of seniors and individuals with disabilities seeking medical weight management.

Frequently Asked Questions

Does this bill cover weight loss drugs for all Medicare patients?
The bill proposes expanding coverage for anti-obesity medications under , subject to specific clinical criteria.
What is the current status of this bill?
As of 2025-06-27, the bill has been introduced and referred to the House Committee on Energy and Commerce and the Committee on Ways and Means.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Expansion of Medicare Drug Coverage

The bill represents a significant shift in federal policy by moving to include anti-obesity medications in the standard Medicare Part D formulary.

Connected Entities

personMs. WatersPrimary sponsor of the bill.Map →
organizationCommittee on Energy and CommerceHouse committee assigned to review the bill.Map →
personMr. Green of TexasCo-sponsor of the bill.Map →
organizationCommittee on Ways and MeansHouse committee assigned to review the bill.Map →
organizationDepartment of Housing and Urban DevelopmentThe Secretary of HUD is responsible for administering the grant program.Map →
personMs. Garcia of TexasCo-sponsor of the bill.Map →
personMs. PressleyCo-sponsor of the bill.Map →

Analysis Score

0–100
  • Significance85
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz50
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record